ArticleJournal of gastroenterology2025

STYK1 as a targetable vulnerability enhances the efficacy of anti-PD-L1 therapy in pancreatic cancer.

Xiao Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.